Bibliotecas PUC-SP - Busca Integrada

Time’s up: mutation rate and lifespan

per Anjali Cremer, Wesley T. Abplanalp, Michael A. Rieger
Publicat a Signal Transduction and Targeted Therapy (2022-08-01)

P1319: TREATMENT WITH MIDOSTAURIN AND OTHER FLT3 TARGETING INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH FLT3 MUTATED AML WHO UN...

per Anjali Cremer, Julius C. Enssle, Saskia Pfaff, Khouloud Kouidri, Fabian Lang, Christian Brandts, Andreas Zeiher, Sebastian Cremer, Björn Steffen, Hubert Serve, Gesine Bug
Publicat a HemaSphere (2023-08-01)

Inflammatory signaling pathways play a role in SYK inhibitor resistant AML

per Sarah Tausch, Christina Villinger, Gabriela Alexe, Daniel J. Urban, Min Shen, Dominique Jahn, Jonas Vischedyk, Sebastian Scheich, Hubert Serve, Matthew D. Hall, Kimberly Stegmaier, Thomas Oellerich, Anjali Cremer
Publicat a Scientific Reports (2025-04-01)